Showing results (31-40 of 69) with videos related to
Sort By:
Pageof 7
The International Journal of Neuropsychopharmacology|June 21, 2015
Protection against Brain Atrophy by Anti-dementia Medication in Mild Cognitive Impairment and Alzheimer's Disease: Meta-Analysis of Longitudinal Randomized Placebo-Controlled TrialsTaro Kishi, Shinji Matsunaga, Kazuto Oya, et al.Journal of Alzheimer'S Disease : JAD|November 20, 2018
Efficacy, Acceptability, and Safety of Intravenous Immunoglobulin Administration for Mild-To-Moderate Alzheimer's Disease: A Systematic Review and Meta-AnalysisMakoto Okuya, Shinji Matsunaga, Toshikazu Ikuta, et al.Journal of Alzheimer'S Disease : JAD|September 19, 2017
Memantine for Alzheimer's Disease: An Updated Systematic Review and Meta-analysisTaro Kishi, Shinji Matsunaga, Kazuto Oya, et al.Journal of Alzheimer'S Disease : JAD|September 25, 2015
Lithium as a Treatment for Alzheimer's Disease: A Systematic Review and Meta-AnalysisShinji Matsunaga, Taro Kishi, Peter Annas, et al.Clinical Case Reports|December 28, 2020
Long-term follow-up of insulin autoimmune syndrome in an elderly patientHiroshi Yoshino, Kyoko Kawakami, Kenji Kohriyama, et al.Neuropsychiatric Disease and Treatment|May 30, 2017
Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese populationTaro Kishi, Toshikazu Ikuta, Shinji Matsunaga, et al.The International Journal of Neuropsychopharmacology|May 16, 2018
Anti-Dementia Drugs for Psychopathology and Cognitive Impairment in Schizophrenia: A Systematic Review and Meta-AnalysisTaro Kishi, Toshikazu Ikuta, Kazuto Oya, et al.Psychopharmacology|May 23, 2018
Folic acid/methylfolate for the treatment of psychopathology in schizophrenia: a systematic review and meta-analysisKenji Sakuma, Shinji Matsunaga, Ikuo Nomura, et al.Nucleic Acids Research|February 7, 2014
DNA-PKcs is required to maintain stability of Chk1 and Claspin for optimal replication stress responseYu-Fen Lin, Hung-Ying Shih, Zengfu Shang, et al.Scientific Reports|April 1, 2017
Tumour blood vessel normalisation by prolyl hydroxylase inhibitor repaired sensitivity to chemotherapy in a tumour mouse modelSatoshi Koyama, Shinji Matsunaga, Masaki Imanishi, et al.Pageof 7